3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
13
Phase 2
6
Phase 1/2
2
Phase NA
1
Phase 4
1
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
4
Genitourinary
2
Breast
2
Tumor-Agnostic
1
Head & Neck
1
Conditions
Neoplasms
1
Interventions
Drug Therapy
5
Docetaxel
3
Bevacizumab
3
icotinib
2
Vincristine
2
Pemetrexed
2
Misoprostol
2
Genes, p53
2
Gemcitabine
2
Dexamethasone
2
Carboplatin
2
Aspirin
2
pinaverium
1
pentetreotide
1
pembrolizumab
1
pazopanib
1
olaparib
1
netupitant, palosentron drug combination
1
nedaplatin
1
lorlatinib
1
durvalumab
1
ceritinib
1
atezolizumab
1
Zoledronic Acid
1
Water
1
Vitamin E
1
Vemurafenib
1
Ultracet
1
Triamcinolone
1
Trastuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
olaparib
×
Tumor-Agnostic
×
Clear all
NCT05078671
2024-06-12
PROACTIVE
Radboud University Medical Center
Phase 4
Recruiting
160 enrolled